209 related articles for article (PubMed ID: 23861852)
1. Epo receptors are not detectable in primary human tumor tissue samples.
Elliott S; Swift S; Busse L; Scully S; Van G; Rossi J; Johnson C
PLoS One; 2013; 8(7):e68083. PubMed ID: 23861852
[TBL] [Abstract][Full Text] [Related]
2. Absence of functional EpoR expression in human tumor cell lines.
Swift S; Ellison AR; Kassner P; McCaffery I; Rossi J; Sinclair AM; Begley CG; Elliott S
Blood; 2010 May; 115(21):4254-63. PubMed ID: 20124514
[TBL] [Abstract][Full Text] [Related]
3. Lack of expression and function of erythropoietin receptors in the kidney.
Elliott S; Busse L; Swift S; McCaffery I; Rossi J; Kassner P; Begley CG
Nephrol Dial Transplant; 2012 Jul; 27(7):2733-45. PubMed ID: 22167585
[TBL] [Abstract][Full Text] [Related]
4. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
[TBL] [Abstract][Full Text] [Related]
5. Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells.
Elliott S; Busse L; McCaffery I; Rossi J; Sinclair A; Spahr C; Swift S; Begley CG
J Immunol Methods; 2010 Jan; 352(1-2):126-39. PubMed ID: 19887071
[TBL] [Abstract][Full Text] [Related]
6. Functional significance of erythropoietin receptor expression in breast cancer.
Arcasoy MO; Amin K; Karayal AF; Chou SC; Raleigh JA; Varia MA; Haroon ZA
Lab Invest; 2002 Jul; 82(7):911-8. PubMed ID: 12118093
[TBL] [Abstract][Full Text] [Related]
7. Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality.
Suzuki N; Ohneda O; Takahashi S; Higuchi M; Mukai HY; Nakahata T; Imagawa S; Yamamoto M
Blood; 2002 Oct; 100(7):2279-88. PubMed ID: 12239135
[TBL] [Abstract][Full Text] [Related]
8. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
[TBL] [Abstract][Full Text] [Related]
9. Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer Cells.
Merkle R; Steiert B; Salopiata F; Depner S; Raue A; Iwamoto N; Schelker M; Hass H; Wäsch M; Böhm ME; Mücke O; Lipka DB; Plass C; Lehmann WD; Kreutz C; Timmer J; Schilling M; Klingmüller U
PLoS Comput Biol; 2016 Aug; 12(8):e1005049. PubMed ID: 27494133
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells.
Fecková B; Kimáková P; Ilkovičová L; Szentpéteriová E; Macejová M; Košuth J; Zulli A; Debeljak N; Hudler P; Jašek K; Kašubová I; Kubatka P; Solár P
BMC Genet; 2019 Jan; 20(1):1. PubMed ID: 30606107
[TBL] [Abstract][Full Text] [Related]
11. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
[TBL] [Abstract][Full Text] [Related]
12. Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models.
LaMontagne KR; Butler J; Marshall DJ; Tullai J; Gechtman Z; Hall C; Meshaw A; Farrell FX
Mol Cancer Ther; 2006 Feb; 5(2):347-55. PubMed ID: 16505108
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
[TBL] [Abstract][Full Text] [Related]
14. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
[TBL] [Abstract][Full Text] [Related]
15. Correlation between erythropoietin receptor(s) and estrogen and progesterone receptor expression in different breast cancer cell lines.
Trošt N; Hevir N; Rižner TL; Debeljak N
Int J Mol Med; 2013 Mar; 31(3):717-25. PubMed ID: 23314808
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin alters gene expression and stimulates proliferation of MCF-7 breast cancer cells.
Trost N; Stepisnik T; Berne S; Pucer A; Petan T; Komel R; Debeljak N
Radiol Oncol; 2013; 47(4):382-9. PubMed ID: 24294184
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
[TBL] [Abstract][Full Text] [Related]
18. Lack of functional erythropoietin receptors of cancer cell lines.
Laugsch M; Metzen E; Svensson T; Depping R; Jelkmann W
Int J Cancer; 2008 Mar; 122(5):1005-11. PubMed ID: 17990315
[TBL] [Abstract][Full Text] [Related]
19. RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
Paragh G; Kumar SM; Rakosy Z; Choi SC; Xu X; Acs G
Am J Pathol; 2009 Apr; 174(4):1504-14. PubMed ID: 19264915
[TBL] [Abstract][Full Text] [Related]
20. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
